IL-22 and IL-22-binding protein (IL-22BP), are significantly upregulated in human HCC tissues as compared with non-tumor liver tissues, and the high expression of IL-22BP is associated with poor prognosis in HCC patients. This evidence concerns the gene IL22 and hepatocellular carcinoma.